Pharma - Health Care Chief

Hengrui

Bristol Myers Squibb signs a $15 billion biobucks agreement to acquire Hengrui assets and take advantage of China’s rapid R&D

Editorial Team

May 14, 2026
4 min read

Valneva

Valneva Set to Let Go of 15% Staff as a Cost-Cutting Measure

Editorial Team

May 14, 2026
4 min read

Angelini

Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion

Editorial Team

May 12, 2026
3 min read

Capricor

Capricor Sues NS Pharma Over Deramiocel Launch Preparations Ahead of FDA Decision

Editorial Team

May 10, 2026
4 min read

Sun Pharma

Sun Pharma to Acquire Organon for $11.75 Billion, Expanding Women’s Health and Biosimilars Portfolio

Editorial Team

April 30, 2026
4 min read